Emerging, Non-PCV13 Serotypes 11A and 35B of Streptococcus pneumoniae Show High Potential for Biofilm Formation In Vitro

Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of age

(2015) Marta C. Nunes et al.   VACCINE

Detection of co-colonization with Streptococcus pneumoniae by algorithmic use of conventional and molecular methods

(2015) Sudipta Saha et al.   VACCINE

Changes in Pneumococcal Serotypes and Antimicrobial Resistance after Introduction of the 13-Valent Conjugate Vaccine in the United States

(2014) Sandra S. Richter et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Decreased Ceftriaxone Susceptibility in Emerging (35B and 6C) and Persisting (19A) Streptococcus pneumoniae Serotypes in the United States, 2011-2012: Ceftaroline Remains ActiveIn Vitroamong β-Lactam Agents

(2014) Rodrigo E. Mendes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fluoroquinolone-Resistant Pneumococci: Dynamics of Serotypes and Clones in Spain in 2012 Compared with Those from 2002 and 2006

(2014) Arnau Domenech et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Smoking and alcohol abuse are the most preventable risk factors for invasive pneumonia and other pneumococcal infections

(2014) Imma Grau et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Low Invasiveness of Pneumococcal Serotype 11A Is Linked to Ficolin-2 Recognition of O-acetylated Capsule Epitopes and Lectin Complement Pathway Activation

(2014) Allison M. Brady et al.   JOURNAL OF INFECTIOUS DISEASES

Emergence of Streptococcus pneumoniae Serogroups 15 and 35 in Nasopharyngeal Cultures From Young Children With Acute Otitis Media

(2014) Judith M. Martin et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Temporal association of infant immunisation with pneumococcal conjugate vaccine on the ecology of Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus nasopharyngeal colonisation in a rural South African community

(2014) S.A. Nzenze et al.   VACCINE

Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England

(2014) Albert Jan van Hoek et al.   VACCINE

Non-invasive pneumococcal serotypes and antimicrobial susceptibilities in a paediatric hospital in the era of conjugate vaccines

(2014) Martha McElligott et al.   VACCINE

Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies

(2014) Laura L Hammitt et al.   Lancet Global Health

Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis

(2014) Lone Simonsen et al.   Lancet Respiratory Medicine

Current concepts in host–microbe interaction leading to pneumococcal pneumonia

(2013) Joshua Vernatter et al.   CURRENT OPINION IN INFECTIOUS DISEASES

In vitrobiofilm formation byStreptococcus pneumoniaeas a predictor of post-vaccination emerging serotypes colonizing the human nasopharynx

(2013) Mirian Domenech et al.   ENVIRONMENTAL MICROBIOLOGY

Surface Charge of Streptococcus pneumoniae Predicts Serotype Distribution

(2013) Yuan Li et al.   INFECTION AND IMMUNITY

Spectrum of Pneumococcal Serotype 11A Variants Results from Incomplete Loss of Capsule O-Acetylation

(2013) J. J. Calix et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Early Trends for Invasive Pneumococcal Infections in Children After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine

(2013) Sheldon L. Kaplan et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Estimating the Burden of Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis of Diagnostic Techniques

(2013) Maria A. Said et al.   PLoS One

Pneumococcal Carriage in Young Children One Year after Introduction of the 13-Valent Conjugate Vaccine in Italy

(2013) Romina Camilli et al.   PLoS One

Colonisation endpoints in Streptococcus pneumoniae vaccine trials

(2013) Kari Auranen et al.   VACCINE

Using the impact of pneumococcal vaccines on nasopharyngeal carriage to aid licensing and vaccine implementation; A Pneumocarr meeting report March 27–28, 2012, Geneva

(2013) David Goldblatt et al.   VACCINE

Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway

(2013) Anneke Steens et al.   VACCINE

Interkingdom Signaling Induces Streptococcus pneumoniae Biofilm Dispersion and Transition from Asymptomatic Colonization to Disease

(2013) L. R. Marks et al.   mBio

The Pneumococcus: Epidemiology, Microbiology, and Pathogenesis

(2013) B. Henriques-Normark et al.   Cold Spring Harbor Perspectives in Medicine

A century of pneumococcal vaccination research in humans

(2012) J.D. Grabenstein et al.   CLINICAL MICROBIOLOGY AND INFECTION

Pneumococcal sepsis and nasopharyngeal carriage

(2012) Bambos M. Charalambous et al.   CURRENT OPINION IN PULMONARY MEDICINE

The fundamental link between pneumococcal carriage and disease

(2012) Birgit Simell et al.   Expert Review of Vaccines

Epidemiology of Invasive Pneumococcal Disease in Older People in Spain (2007–2009): Implications for Future Vaccination Strategies

(2012) Carmen Ardanuy et al.   PLoS One

Associations between Pathogens in the Upper Respiratory Tract of Young Children: Interplay between Viruses and Bacteria

(2012) Menno R. van den Bergh et al.   PLoS One

High Levels of Genetic Recombination during Nasopharyngeal Carriage and Biofilm Formation in Streptococcus pneumoniae

(2012) L. R. Marks et al.   mBio

Effect of Seven-Valent Pneumococcal Conjugate Vaccine on Staphylococcus aureus Colonisation in a Randomised Controlled Trial

(2011) Elske J. M. van Gils et al.   PLoS One

Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model

(2011) Julie M. Skinner et al.   VACCINE

Biofilm formation in Streptococcus pneumoniae

(2011) Mirian Domenech et al.   Microbial Biotechnology

Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?

(2010) William P Hausdorff et al.   BMC Pediatrics

Versatility of the capsular genes during biofilm formation byStreptococcus pneumoniae

(2009) Mirian Domenech et al.   ENVIRONMENTAL MICROBIOLOGY

Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis

(2009) Heather E. Hsu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pneumococcal Capsular Polysaccharide Structure Predicts Serotype Prevalence

(2009) Daniel M. Weinberger et al.   PLoS Pathogens